Oslo Trial

Business

Voyager Breaks Ground on Major Pueblo Defense Complex, Signaling U.S. Industrial Base Push

Voyager Technologies has commenced a significant expansion of its defense manufacturing facility in Pueblo, Colorado, marking one of the region's largest military-industrial investments in recent years. The project aims to bolster domestic production for missile defense and munitions, integrating advanced automation and AI-driven logistics.

Jan 30, 2026

Business

Genmab Shares Face Target Cut After EPKINLY Trial Misses Survival Goal, But Analysts Keep Faith

H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.

Jan 30, 2026

Business

Fortive's Stock Slump Sparks Valuation Debate: Is the Industrial Tech Firm a Bargain?

Fortive Corporation's shares have retreated over 5% in the past month, prompting investors to re-examine the industrial technology conglomerate's fundamentals. With a renewed focus on its recurring revenue streams and a fair value estimate suggesting upside, analysts are divided on whether the pullback presents a buying opportunity or reflects deeper sector headwinds.

Jan 30, 2026

Sanofi Halts mRNA Flu Vaccine Trial Amid Surging U.S. Influenza Season

French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.

Feb 2, 2026

Business

Altimmune Secures Analyst Backing as Pemvidutide Advances Toward Phase 3 MASH Trial

Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.

Feb 2, 2026

Business

Beyond the AI Hype: Why Giverny Capital Is Betting on Industrial Stalwart Hawkins (HWKN)

Amid a market obsessed with artificial intelligence, investment firm Giverny Capital reveals a new position in Hawkins, Inc., a specialty chemicals manufacturer. We examine the rationale behind this contrarian bet and what it says about current market dynamics.

Feb 2, 2026

Business

Palantir Cements AI Ambitions with Major Korean Industrial Deal and European Sovereign AI Infrastructure Project

Palantir Technologies expands its strategic footprint in Asia through a deepened partnership with HD Hyundai, while securing a pivotal role in building sovereign AI data centers across Europe, the Middle East, and Africa with Sovereign AI and Accenture.

Feb 2, 2026

Business

Rockwell Automation Powers Saudi Arabia's First EV Factory, Bolstering Its Industrial Software Ambitions

Rockwell Automation expands its partnership with Lucid Motors, deploying its FactoryTalk MES software and training programs at Saudi Arabia's inaugural electric vehicle production hub. The move aligns with the Kingdom's Vision 2030, positioning Rockwell as a key player in the region's high-tech manufacturing transformation.

Jan 30, 2026

World

Meta Faces Landmark Trial in New Mexico Over Allegations of Enabling Child Exploitation

Meta Platforms heads to a Santa Fe courtroom next week to defend itself in a high-stakes lawsuit. The State of New Mexico alleges the social media giant's platforms facilitated the sexual exploitation of minors and harmed their mental health for profit, marking the first such case against Meta to reach a jury.

Jan 30, 2026

Business

Thermon Group Holdings: A Closer Look at the Industrial Heating Specialist's Investment Case

Amidst a market often captivated by speculative stories, Thermon Group Holdings (NYSE: THR) presents a profile built on profitability, steady growth, and aligned leadership—factors that seasoned investors typically watch for.

Jan 30, 2026

Business

Kadant Inc. Valuation Analysis: Is the Industrial Stock Priced for Perfection?

A deep dive into Kadant Inc.'s intrinsic value using a Discounted Cash Flow model suggests the stock is trading near its estimated fair value of $273, raising questions about its near-term upside potential amid current market prices.

Jan 30, 2026

Business

Linde's Stock Momentum: Is the Industrial Gas Giant Undervalued After Recent Gains?

Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.

Jan 30, 2026

World

Norwegian Royal Family Under Dual Scrutiny: Crown Princess's Son Faces New Assault Charges as Epstein Links Resurface

Marius Borg Høiby, son of Crown Princess Mette-Marit, was arrested on new violent charges days before his rape trial, casting a shadow over the monarchy just as his mother faces renewed criticism over her past association with Jeffrey Epstein.

Feb 2, 2026

Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Jan 31, 2026

Business

Beyond the Chatbot: Veteran Analyst Pivots AI Investment Thesis to Physical World, Backs Tesla and Nvidia

As Wall Street remains fixated on software-based AI, a leading tech analyst argues the next trillion-dollar opportunity lies in 'physical AI'—machines that see, move, and act. Dan Ives of Wedbush singles out Tesla and Nvidia as the indispensable architects of this new industrial revolution.

Feb 2, 2026

Business

Caterpillar's AI-Powered Surge: Can the Dow's 2025 Champion Keep Climbing in 2026?

Caterpillar, the industrial titan, rode the AI infrastructure wave to become the top-performing Dow stock in 2025. With record earnings on the horizon, investors are asking if its momentum can defy high valuations and continue into the new year.

Feb 2, 2026

Business

Silver's Meteoric Rise: Analysts See Path to $150 as New Era Dawns

Silver's explosive surge past $100 has reshaped the commodity landscape. With Citi and prominent strategists forecasting a run toward $150, the metal is now seen as a volatile barometer of macro fears, structural deficits, and relentless industrial demand, establishing a potential new floor above $65.

Feb 2, 2026

Business

3M's Rocky Road: Analysts Hold Steady Despite Stock Lagging Behind Market Rally

While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.

Feb 2, 2026

Sanofi's Long-Delayed Rare Disease Drug Shows Promise for Neurological Gaucher, Falters in Fabry

After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.

Feb 2, 2026

Business

S&P 500 Earnings Surge Past Forecasts, Fueling Market Optimism

Fourth-quarter earnings for S&P 500 companies are significantly outperforming expectations, led by robust growth in industrial and tech sectors, as investors await a busy week of corporate results and key economic data.

Feb 2, 2026